CJC-1295 / Ipamorelin (No DAC)

Description

Research Overview:

This combination includes a growth hormone releasing hormone (CJC-1295 without DAC) and a ghrelin receptor agonist (Ipamorelin), studied for pulsatile GH signaling.

Mechanism of Action:

CJC-1295 stimulates GHRH receptors while Ipamorelin selectively activates ghrelin receptors, influencing endogenous growth hormone release pathways.

Areas of Scientific Interest:

• Endocrine signaling
• Growth hormone pulsatility
• Metabolic regulation

Disclaimer:

This is for laboratory research only, not intended for human or animal consumption.